By utilizing our TGFβ2-induced ocular hypertension model, we have identified toll-like receptor 4 (TLR4) signaling as a novel molecular pathway involved in the development and progression of glaucomatous TM damage [3]. Here, TLR4 is linked to ocular hypertension.